Member Info for Leggster

Traded volume has been low now for some time, which is not really a surprise as holders will understand the risk and be waiting out the trial. I was a little surprised with no tick up on the patent news however the days are passing and there will one way or another be news coming in due course. Many of us expect this to be good both in terms of the trial and 737 and also expect a 1801 deal either near the end or shortly following the trial. IMO we are undervalued as things stand any substantive news should see us gap upwards. GLA

Nothing to dislike here, someone needs some money for their own purposes, I expect the SP to return to the prior level tomorrow. Then it's back to waiting for news. No RNS around pausing the trial to investigate unexpected outcomes, this suggest things are going to plan and I expect an update RNS on the trial soon. Cambridge Business News last week, if trying to build a steady IR flow perhaps a tweet or RNS for the end of this week, then something else next week perhaps another article in trade press to keep the Sareum name in sight. GLA

Still low volume but at least the sp is holding firm giving a nice launch point when we get hopefully a positive update in the near future. Lots of possible upside in the near future. 737 is the great unknown for me, I choose to trust the board and the combo research but the type and structure of deal will be important. Enough upfront payments to take 1802 into clinic would be great with milestones that create demand for the stock would be a great outcome. Then add an 1801 deal on top and I feel our return will be very pleasant.

No volume continues as everyone waits for news, trial ongoing ,737 waiting in the wings, exciting but also dull times whilst waiting, everyday without bad news is great but would be even better to see a positive interim update. GLA

Tiny volume while we await news, regular trail updates and the possibility of 737 news undoubtedly means that only those with immediate need of funds are selling. Bad news during trial would be released immediately so feel confident as days roll past that there will be positivity to share. Once we get a few weeks into trial things will be more interesting/nervy. GLA

Yes if they are sticking with their stated strategy we should as others have already stated agree a deal on 1801 over the coming months, there is no reason IMO that this will not already have been agreed and trigger based on reaching a targeted dosage without unexpected outcomes. Added to that we may see a 737 deal (perhaps Merck or Roche) which would give us a strong boost. This for me gets us to the point where existing HNWI warrants can be executed extending the cash runway to allow time to fund moving forward based on milestone payments. With the wild card of a takeover possible once the SP achieves what the BOD see as a sensible level. Great day GLA

Yes the news will come out in its own time, a slight delay may even be a good thing if we see a drift up before the news. GLA

My condolences his insight and commentary were invaluable

I'll go for £1.70, feels great to be in an active news period, let's hope we can use the news drops to boost the company profile,

Well predicted, looking forward to next week GLA

Yes would be fascinating to know how many more chunks the transaction is bring broken into, a nice lead into next week, GLA

Yes from a personal perspective I have invested what I am willing to risk at this point, I may invest more as news lands further derisking the investment. My own view is that this phase will pass smoothly, I do trust the science and the BOD comments re toxicity and feel there are enough drugs in progress in this space to have confidence. Clearly there could be a risk if issues at very high doses but I hope/expect a clean progression at low doses. But back to your point I am at my maximum investment without some news either on 737 or 1801. I debate my exit plan with myself regularly but will hold for multiples of the current SP GLA

Yes I thought we would seeing buying this week, a drop to catch some stop losses is always a risk to the unwary, looking forward to the next few weeks where we hopefully see no unexpected outcomes. GLA

The BOD often gets a dose of constructive criticism on this board. Sometimes deserved but mainly in my opinion unjustified, I am also invested in RENE and joined their preliminary results call today. All I can say is that the SAR BOD look like superstars, even with squeaky chairs. Exciting weeks ahead, although I am starting to get nervous on 737 I had hoped for news by now, however I know that contracts can take time to finalise as our Legal friends need to make a crust. GLA

It all feels a little attritional waiting for news on 737, what date do posters guess we will see the first dosing on 1801, I quite fancy the 29th May based on the logic that for once the BOD would like to over deliver against their prior guidance. GLA

It would be great if once 1801 and 1802 are progressing in clinic and 737 is relincensed if John and Tim could look again at FLT3 and find a way to address the solubility issues.

Here's a link

https://www.cambridgenetwork.co.uk/news/link-china-pharma-solutions-brokers-sareum-co-development-agreement-china-auroraflt3

If you google now it comes back with Hebei Medical University Biomedical Engineering Center (HMUBEC) . HMUBEC is a subsidiary of Hebei Medical University Science & Technology General Company (HMUSTGC) as the partner

I was surprised by todays trading, but tend to agree that it was triggered by the Edison article. I would though expect recovery and a move back into a rise. We have sufficient funds for the current trial. We probably have more cash coming from 737, Edison's coverage might result in more HNWI investments, or we do a raise. If we raise to progress deeper into trials this will ultimately increase returns. IMO a temporary dip which I think will quickly be recovered and past. GLA

Exciting times ahead of us now that we are in clinic. I hope that we will receive timely updates on progress. Alongside that news on 737 with some FOMO and perhaps belief that an 1801 deal will be agreed before the end of trial. Will hopefully see this SP moving upwards. I'm not a chartist but commentary in that space also seems positive and I do wonder if PH may finally deliver II's now that we are in clinic. GLA